Trading ideas: Duopharma Biotech, Pharmaniaga, Salcon, Digi, TNB, Advancecon, Microlink


  • Corporate News
  • Wednesday, 15 Jul 2020

KUALA LUMPUR: Duopharma Biotech Bhd, Pharmaniaga Holdings Bhd, Salcon Bhd, Digi.com Bhd, Tenaga Nasional Bhd, Advancecon Holdings Bhd and Microlink Solutions Bhd are among the stocks to watch on Wednesday, according to JF Apex Research.

Duopharma Biotech and Pharmaniaga will be undertaking the fill and finish processes for the Covid-19 vaccine, once a vaccine is developed, said Science, Technology and Innovation Minister Khairy Jamaluddin.

Salcon’s wholly-owned subsidiary Salcon Engineering Bhd has inked a joint venture agreement with Hong Kong’s The One Smart City Development Ltd (TOSC) via its subsidiary Wide Plus Smart City Sdn Bhd to market and deploy smart water systems in Malaysia.

DiGi.Com’s 2QFY20 net profit fell 26.6% year-on-year due to the impact of the Covid-19 outbreak.

Tenaga Nasional said it has received a notice of additional assessment for the year of assessment 2018 amounting to RM1.81bil from the Inland Revenue Board.

Advancecon has bagged a RM19.85mil contract to undertake earthworks and other related works at Sime Darby Property Bhd’s Bandar Bukit Raja 2 development in Klang, Selangor.

Microlink Solutions, whose share price rose to a four-year high yesterday, has received an unusual market activity (UMA) query by Bursa Malaysia Securities.

Glomac reported a net loss of RM8.61mil for its 4QFY20, from a net profit of RM11.21mil a year ago as impacted by a recognition of fair value losses on its investment properties.

Meanwhile, US markets rose overnight following corporate results and developments in the coronavirus vaccine.

Earlier, European stocks tumbled as rising coronavirus cases affected investor sentiment.

“Following the mixed performances in the US and Europe, the FBM KLCI could hover sideways

below the resistance of 1,615 points,” JF Apex said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Duopharma Biotech , Pharmaniaga , Salcon , Digi , TNB

   

Did you find this article insightful?

Yes
No

Across the site